Correction: Vol. 32, No. 1

Slightly more than one third (35.7%, 35/98) of respondents reported following specific guidelines for M. tuberculosis infection screening in pregnant women, predominantly international guidelines (6-8) and, to a lesser extent, national guidelines (9,10).However, only 23.2% (23/99) considered the available guidelines adequate.Guideline limitations included a lack of evidence specific to pregnancy, insufficient guidance on when and how to screen and treat pregnant women, and inconsistent national recommendations.Respondents noted training gaps, and one third of participants had received no specific training on M. tuberculosis infection screening and treatment.Respondents emphasized the need for additional resources, particularly standardized protocols, training, better access to guidelines, and the involvement of cultural mediators.In this query among clinicians in Europe, respondents reported substantial heterogeneity in M. tuberculosis infection screening and TPT practices for pregnant migrants.Screening was most often restricted to women with specific risk factors, and diagnostic and preventive approaches varied widely across settings.Given the convenience sampling approach and the open-link dissemination strategy (response rates not assessable), the patterns described here should not be interpreted as representative of all settings in Europe.However, the responses to our query underscore areas of clinician uncertainty regarding M. tuberculosis infection screening and treatment in pregnant women that warrant further investigation, training, and guidelines.